This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Donors of organs and tissues
Z21_DONORS_ORGANS_TISSU
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
577 |
4. Check minimum number of eventsNone |
577 |
5. Include endpointsNone |
577 |
6. Filter based on genotype QC (FinnGen only) |
542 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Donors of organs and tissues
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 542 | 317 | 225 |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | 0.10 |
| Median age at first event (years) | 48.14 | 47.46 | 49.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 577
- Matched controls
- 5770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z52.4
ICD-10 Finland
Kidney donor
+∞
246.0
218
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
170.5
155
*
L03AA02
ATC
filgrastim; parenteral
31.7
167.1
113
44
Z00.5
ICD-10 Finland
Examination of potential donor of organ and tissue
1947.6
157.9
146
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
22.2
150.9
118
66
WW409
NOMESCO Finland
Other aferesis
728.0
123.1
117
*
Z52.9
ICD-10 Finland
Donor of unspecified organ or tissue
+∞
116.7
108
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
25.3
109.2
79
36
XW000
NOMESCO Finland
Bone marrow biopsy
17.7
102.9
88
58
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
341.9
88.3
87
*
YKA01
NOMESCO Finland
Percutaneous endoscopic excision of kidney from living donor
+∞
82.3
77
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
193.4
81.5
83
5
Z52.3
ICD-10 Finland
Bone marrow donor
+∞
77.9
73
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.3
72.7
81
82
WW500
NOMESCO Finland
Blood transfusion
13.4
68.0
67
56
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
13.5
63.5
62
51
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
21.6
60.6
46
23
C90.0
ICD-10 Finland
Multiple myeloma
102.7
59.2
64
7
153
Kela drug reimbursment
Lenalidomid
148.6
51.8
54
*
L04AX04
ATC
lenalidomide; oral
145.6
50.7
53
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
16.7
49.0
42
27
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.5
47.3
137
370
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
13.9
46.5
44
34
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
170.2
45.5
47
*
329
Kela drug reimbursment
Lenalidomide
231.8
42.5
43
*
M04AA01
ATC
allopurinol; systemic
5.2
40.8
93
205
H02AB02
ATC
dexamethasone; systemic
4.9
39.1
95
221
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
208.7
38.3
39
*
A04AA01
ATC
ondansetron; systemic, rectal
5.6
36.8
75
149
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
51.4
36.2
43
9
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
127.7
34.1
36
*
L03AA13
ATC
pegfilgrastim; parenteral
6.9
30.4
49
77
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.2
30.3
155
600
J05AB11
ATC
valaciclovir; oral
3.3
29.1
131
469
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
30.3
27.9
37
13
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.9
26.5
50
92
JN4AD
NOMESCO Finland
Body CT examination
4.4
26.4
72
182
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.2
26.1
57
120
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
31.5
23.0
30
10
KA1FN
NOMESCO Finland
Isotope renography
42.0
22.9
28
7
N02AA05
ATC
oxycodone; systemic
3.6
22.9
84
262
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.1
22.7
68
184
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
22.6
252
1411
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
114.2
20.7
22
*
GD1AD
NOMESCO Finland
Thorax CT examination
5.0
20.4
46
99
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
33.9
20.3
26
8
L04AX06
ATC
pomalidomide; oral
68.9
17.8
20
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
68.9
17.8
20
*
B03XA02
ATC
darbepoetin alfa; parenteral
20.8
16.5
24
12
AA1AA
NOMESCO Finland
Head X-ray examination
25.3
16.1
22
9
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.4
16.0
32
62
Z52.8
ICD-10 Finland
Donor of other organs and tissues
+∞
15.7
15
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
19.0
14.8
22
12
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
14.6
14
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
153.7
14.5
15
*
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
37.1
14.5
18
5
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
19.8
14.3
21
11
393
Kela drug reimbursment
Pomalidomide
54.7
13.9
16
*
1507
Kela drug reimbursment
Pomalidomide
54.7
13.9
16
*
TGC00
NOMESCO Finland
Bronchial lavation
6.7
13.7
22
34
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
13.6
13
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.4
13.6
27
52
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.8
13.3
72
280
JN4BD
NOMESCO Finland
Extensive body CT
3.1
12.7
56
194
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
12.5
80
339
R4110
NOMESCO Finland
Physiotherapy
2.0
11.5
143
799
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
122.4
11.5
12
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.5
11.4
22
41
JN6AD
NOMESCO Finland
CT of torso and neck
9.2
11.4
23
26
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.9
11.0
33
89
WF049
NOMESCO Finland
Radiotherapy of metastasis
9.9
10.8
21
22
J01MA12
ATC
levofloxacin; systemic
2.3
10.8
93
450
Z52.2
ICD-10 Finland
Bone donor
+∞
10.4
10
*
YKA00
NOMESCO Finland
Excision of kidney from living donor
+∞
10.4
10
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
10.3
72
317
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
23.9
10.3
14
6
C83.1
ICD-10 Finland
Mantle cell lymphoma
40.8
10.0
12
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.6
9.8
22
30
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.2
9.5
25
61
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
101.6
9.4
10
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
101.6
9.4
10
*
V590A
ICD-9 Finland
Donors, Blood
101.6
9.4
10
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.9
9.4
19
22
R50.9
ICD-10 Finland
Fever, unspecified
2.1
9.0
89
454
WX402
NOMESCO Finland
General anaesthesia
2.0
8.9
118
669
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
8.7
60
263
WZC30
NOMESCO Finland
Teaching
2.2
8.6
80
398
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.0
8.4
14
11
YKA02
NOMESCO Finland
Excision of kidneys from cadaver donor
+∞
8.4
8
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
7.8
105
597
J02AC03
ATC
voriconazole; systemic
45.6
7.7
9
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
45.6
7.7
9
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.7
7.7
43
170
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.5
101
575
Z51.6
ICD-10 Finland
Desensitization to allergens
81.1
7.4
8
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.8
7.3
36
133
127
Kela drug reimbursment
Transplant complication
11.1
7.3
13
12
Y7039, ,
ICD-8 Finland
+∞
7.3
7
*
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
7.3
7
*
7153
FHL
Renal excision of a living donor
+∞
7.3
7
*
L04AX02
ATC
thalidomide; oral
+∞
7.3
7
*
J05AB01
ATC
aciclovir; systemic
1.8
7.2
123
755
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
20.3
7.2
10
5
Z31.6
ICD-10 Finland
General counselling and advice on procreation
6.8
6.9
16
24
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
40.5
6.8
8
*
A04AA02
ATC
granisetron; systemic, transdermal
3.1
6.6
27
90
Z90.5
ICD-10 Finland
Acquired absence of kidney
70.6
6.4
7
*
398
Kela drug reimbursment
Ixazomib
70.6
6.4
7
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
70.6
6.4
7
*
1505
Kela drug reimbursment
Ixazomib
70.6
6.4
7
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.8
6.4
19
51
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.6
6.3
17
31
J01MA14
ATC
moxifloxacin; systemic
2.4
6.3
45
200
WW402
NOMESCO Finland
Leucoferesis
+∞
6.3
6
*
L01EL01
ATC
ibrutinib; oral
+∞
6.3
6
*
L01XG03
ATC
ixazomib; oral
+∞
6.3
6
*
H02AB09
ATC
hydrocortisone; systemic
4.0
6.2
17
43
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
10.2
6.1
11
11
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.8
6.0
30
112
A10BA02
ATC
metformin; oral
0.4
6.0
37
791
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
248
96
44.55
307.65
1.9
1.1
—
—
—
0
0
232
79
48.44
307.65
1.7
1.2
10.69
—
u/ml
—
6
0
195
91
31.86
274.80
1.8
1.2
210.40
232.31
u/ml
0.32
121
54
176
76
32.88
254.44
1.5
1.2
120.67
111.53
u/ml
0.43
39
15
135
30
58.44
235.08
1.9
7.7
—
48.10
—
0
10
86
11
91.70
163.28
3.4
2.5
—
—
—
0
0
86
11
91.70
163.28
3.3
2.5
—
—
—
0
0
86
11
91.70
163.28
3.3
2.5
—
—
—
0
0
87
13
78.63
161.50
3.4
2.4
—
—
—
0
0
87
13
78.63
161.50
3.4
2.4
—
—
—
0
0
119
72
20.56
146.59
5.9
4.6
374.50
292.44
iu/ml
—
22
9
91
32
33.57
138.55
3.4
2.2
—
—
—
0
0
83
22
43.90
136.92
3.7
2.2
—
—
—
0
0
93
37
29.77
135.81
3.4
2.1
—
—
—
0
0
87
30
33.97
133.16
3.4
2.0
—
—
—
0
0
87
30
33.97
133.16
3.4
2.0
—
—
—
0
0
87
30
33.97
133.16
3.4
2.0
—
—
—
0
0
132
8
213.25
131.72
1.9
1.1
—
—
—
0
0
93
46
23.91
124.74
3.4
1.8
—
—
—
0
0
149
192
10.11
113.88
1.2
1.3
—
—
—
0
0
91
54
19.82
112.31
3.4
1.7
—
—
—
0
0
91
54
19.82
112.31
3.4
1.7
—
—
—
0
0
62
11
63.03
111.05
2.5
1.0
—
—
—
0
0
61
11
61.89
108.90
2.5
1.0
—
—
—
0
0
61
11
61.89
108.90
2.5
1.0
—
—
—
0
0
61
11
61.89
108.90
2.5
1.0
—
—
—
0
0
95
71
15.82
103.93
3.4
1.7
—
—
—
0
0
70
27
29.37
102.73
5.2
2.3
0.74
2.19
g/24h
1.95
43
18
95
73
15.38
102.27
1.0
1.1
—
—
—
0
0
65
23
31.72
98.08
1.3
1.1
—
—
—
0
0
91
71
15.03
96.98
3.5
1.7
—
—
—
0
0
297
913
5.64
94.73
5.0
1.8
—
—
—
0
0
113
128
10.73
94.42
5.1
1.8
—
—
—
0
0
53
10
58.26
93.57
1.0
1.3
—
—
—
0
0
89
76
13.66
89.73
1.1
1.2
2.56
3.75
u/ml
0.59
36
32
82
64
14.77
87.14
2.5
1.1
—
—
—
0
0
73
46
18.02
87.01
2.8
1.2
—
—
—
0
0
73
46
18.02
87.01
2.8
1.2
—
—
—
0
0
73
47
17.64
86.06
2.8
1.2
—
—
—
0
0
73
47
17.64
86.06
2.8
1.2
—
—
—
0
0
73
47
17.64
86.06
2.8
1.2
—
—
—
0
0
86
77
12.95
84.04
1.1
1.2
2.50
5.04
u/ml
0.44
22
27
71
47
17.09
82.45
2.9
1.2
—
—
—
0
0
46
10
49.90
78.67
3.8
2.5
—
—
—
0
0
113
185
7.35
68.83
5.8
2.7
1.51
1.64
mmol/l
0.14
97
131
92
124
8.64
66.37
3.3
1.6
—
—
—
0
0
71
70
11.43
64.74
18.3
4.1
—
1.20
—
0
6
380
1765
4.38
64.31
19.5
5.0
1.22
1.22
mmol/l
0.05
354
1522
73
82
10.05
60.60
2.8
1.2
—
—
—
0
0
351
1598
4.05
59.76
11.7
4.6
1.22
1.22
mmol/l
0.19
343
1461
56
47
13.09
56.50
2.0
2.3
—
—
—
0
0
47
31
16.42
54.26
3.8
1.9
335.60
614.58
e6/l
3.30
47
31
134
340
4.83
50.24
15.2
4.3
215.87
230.03
u/l
1.02
129
325
136
356
4.69
48.97
1.6
2.5
—
—
—
0
0
109
240
5.37
48.22
2.6
2.9
63.68
69.58
ng/l
0.59
102
220
172
548
4.05
47.55
2.7
2.4
3.63
2.66
e6/l
0.55
94
285
390
2105
3.63
47.19
9.0
5.7
29.92
29.64
%
0.21
380
1995
321
1539
3.45
47.07
7.0
8.5
1.13
1.14
inr
0.06
60
497
388
2091
3.61
46.98
7.6
5.4
54.08
55.98
%
3.18
376
1982
373
1967
3.54
46.66
5.5
2.2
—
—
—
0
0
43
32
14.44
46.40
1.3
1.7
—
—
—
0
0
101
217
5.43
45.84
3.0
1.4
—
—
—
0
0
317
1526
3.39
45.83
6.7
3.8
36.83
37.27
g/l
0.84
311
1435
84
155
6.17
44.84
2.7
1.4
—
—
—
0
0
174
586
3.82
44.06
2.6
2.3
0.78
0.92
e6/l
0.28
101
318
155
491
3.95
42.78
4.4
1.7
—
—
—
0
0
255
1114
3.31
42.63
3.4
2.5
12.30
70.44
e6/l
3.03
210
833
120
319
4.49
41.97
3.5
2.5
1.50
1.74
%
2.54
115
296
286
1349
3.22
41.78
3.7
2.6
—
—
—
0
0
233
1016
3.17
38.28
3.1
2.5
0.14
0.34
e6/l
1.64
181
749
235
1035
3.14
37.87
3.5
2.3
300.53
5876.28
umol/l
3.79
224
938
113
333
3.98
34.00
12.1
2.4
8.64
10.76
g/l
5.94
106
304
404
2493
3.07
33.96
13.9
8.0
3.21
3.95
e9/l
14.13
357
2188
143
497
3.50
33.65
2.6
1.8
27.55
29.33
s
4.10
136
483
235
1108
2.89
32.54
3.1
3.8
10.49
9.07
mg/mmol
0.10
130
703
80
194
4.63
31.04
1.4
1.3
—
—
—
0
0
38
44
9.17
30.47
1.1
1.0
—
—
—
0
0
222
1054
2.80
29.85
2.9
3.2
337.62
180.78
mg/l
0.21
121
692
102
316
3.71
28.28
2.5
2.0
63.32
77.00
ml/min/173m2
3.62
47
116
244
1277
2.58
26.29
2.6
3.1
7.70
8.31
mmol/l
1.33
236
1103
171
757
2.79
25.73
2.5
2.1
4.35
7.11
e6/l
1.06
159
679
50
104
5.17
23.14
8.6
1.8
—
—
—
0
0
66
179
4.03
21.94
2.9
2.0
0.06
0.18
e6/l
1.40
66
171
356
2335
2.37
21.93
5.4
3.8
6.05
6.52
mmol/l
6.89
342
2145
82
264
3.45
21.20
2.4
2.5
2.09
1.70
mmol/l
0.62
74
216
48
109
4.71
20.02
1.5
2.2
1.71
1.27
g/l
1.35
43
95
397
2815
2.32
19.15
4.0
3.4
716.17
1223.13
e6/l
—
6
30
39
93
4.43
15.29
1.3
1.3
3.11
3.28
ug/l
0.15
39
87
426
3264
2.17
14.80
13.8
6.1
70.19
73.24
u/l
1.45
418
3055
200
1238
1.94
12.14
2.9
2.5
2.33
2.36
mmol/l
2.69
182
1112
427
3389
2.00
11.90
3.3
2.8
35.34
40.47
u/l
1.40
414
3202
28
63
4.62
11.78
1.7
1.8
—
—
—
0
0
28
71
4.09
10.15
1.0
1.0
—
—
—
0
0
18
19
9.74
9.32
1.7
1.1
—
—
—
0
0
21
30
7.22
9.10
1.0
1.1
—
—
—
0
0
296
2216
1.69
8.69
5.0
4.0
0.00
0.00
estimate
0.50
42
440
298
2241
1.68
8.55
3.4
2.9
0.00
0.01
estimate
0.50
42
412
295
2213
1.68
8.54
3.4
2.9
0.00
0.00
estimate
0.50
44
445
528
4715
2.41
8.33
24.9
9.3
22.38
21.22
mg/l
0.36
463
3555
15
14
10.96
8.33
1.1
1.4
—
—
—
0
0
92
491
2.04
8.23
3.5
3.8
29.83
31.68
%
0.82
75
337
19
46
4.24
7.32
1.2
1.5
—
—
—
0
0
7
0
+∞
7.30
1.6
0.0
—
—
—
0
0
18
43
4.29
7.06
1.2
1.6
—
—
—
0
0
435
3714
1.70
6.84
4.1
3.4
—
—
—
0
0
12
11
11.11
6.82
1.1
1.4
—
—
—
0
0
80
439
1.95
6.58
2.2
1.8
25.58
24.50
%
0.28
73
386
17
30
5.80
6.49
1.2
1.2
—
—
—
0
0
10
7
14.51
6.41
3.1
1.1
0.97
3.86
mmol/l
—
10
7
84
476
1.90
6.28
2.1
1.8
2.28
2.43
g/l
1.67
79
441
16
28
5.84
6.18
1.3
1.6
—
—
—
0
0
264
2045
1.54
5.94
16.0
5.0
9.42
10.81
umol/l
3.06
257
1927
29
108
2.77
5.84
1.7
1.9
260.33
225.38
ug/l
0.11
24
99
23
75
3.15
5.83
3.2
2.7
—
—
—
0
0
19
56
3.47
5.63
1.2
1.5
—
—
—
0
0
123
809
1.66
5.50
3.4
2.3
442.35
563.48
ng/l
0.79
103
655
19
58
3.35
5.35
1.2
1.5
—
—
—
0
0
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
8
6
13.49
5.09
1.1
1.3
—
—
—
0
0
512
4694
1.81
4.86
24.3
9.8
139.71
139.73
mmol/l
0.08
507
4558
513
4711
1.80
4.77
24.5
9.9
3.92
3.94
mmol/l
1.04
506
4562
7
5
14.15
4.58
16.4
9.2
0.16
0.22
umol/l
—
7
5
490
4459
1.66
4.52
15.7
8.3
81.79
90.12
ml/min/173m2
11.85
407
3561
10
17
5.97
4.14
1.1
1.1
—
—
—
0
0
191
1487
1.43
3.77
2.6
3.1
27.18
31.12
u/l
1.74
184
1412
56
332
1.76
3.64
1.5
1.6
—
—
—
0
0
165
1261
1.43
3.58
2.4
2.3
60.84
61.73
u/l
0.07
160
1173
218
1752
1.39
3.54
2.1
2.1
77.38
74.60
nmol/l
0.76
205
1600
83
554
1.58
3.45
2.6
1.9
—
—
—
0
0
252
2089
1.37
3.33
2.8
2.5
239.74
92.30
ug/l
3.17
243
1958
10
24
4.22
3.20
1.0
1.0
977.30
1582.79
miu/ml
—
10
24
36
194
1.91
3.19
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
67
2.58
3.15
3.1
2.5
0.30
0.33
u/ml
0.15
11
34
536
5091
1.74
3.01
16.0
8.1
25.10
27.70
u/l
4.11
527
4939
14
51
2.79
3.00
1.6
1.4
153.77
181.88
pmol/l
0.33
14
51
82
566
1.52
2.95
1.9
1.6
963.22
1233.61
nmol/l
2.81
73
441
28
142
2.02
2.95
2.6
2.6
25.68
24.87
mmol/l
0.90
28
137
68
453
1.57
2.87
2.5
1.8
—
—
—
0
0
485
4520
1.46
2.79
4.4
3.5
1.18
1.28
mmol/l
3.07
471
4239
8
19
4.25
2.68
1.6
1.8
1086.88
472.47
u/ml
—
8
19
9
24
3.79
2.68
2.2
2.9
39144.44
42420.83
ug/l
—
9
24
450
4151
1.38
2.65
4.1
4.7
36.59
38.59
mmol/mol
7.06
436
3913
10
30
3.37
2.61
1.2
1.0
—
—
—
0
0
107
804
1.41
2.50
1.5
1.4
21.63
20.70
nmol/l
0.21
98
680
25
133
1.92
2.35
1.1
1.8
—
153.33
—
0
6
6
13
4.65
2.27
1.0
1.2
—
—
—
0
0
6
13
4.65
2.27
2.5
1.8
—
—
—
0
0
6
13
4.65
2.27
1.5
1.5
—
—
—
0
0
139
1107
1.34
2.26
1.9
1.9
180.40
258.40
u/l
0.63
134
1046
117
909
1.36
2.23
2.1
1.9
2.80
2.87
mg/l
0.15
97
765
563
5479
2.14
2.16
30.9
14.2
4.38
4.61
e12/l
15.68
548
5347
6
14
4.32
2.15
1.2
1.1
—
—
—
0
0
122
964
1.34
2.08
2.0
1.6
0.99
0.96
mg/l
0.07
89
707
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
562
5473
2.03
2.03
31.0
14.2
235.00
254.93
e9/l
9.93
545
5350
5
11
4.57
1.94
2.0
1.9
—
—
—
0
0
53
367
1.49
1.92
10.4
6.5
107.08
104.20
mmol/l
4.01
53
367
7
22
3.21
1.88
2.3
2.1
—
—
—
0
0
5
12
4.19
1.82
1.2
1.2
—
—
—
0
0
561
5472
1.91
1.82
31.2
14.2
39.54
41.96
%
2.22
549
5194
9
35
2.60
1.80
1.0
1.1
—
—
—
0
0
493
4689
1.35
1.80
4.0
3.8
1.49
1.46
mmol/l
0.77
478
4422
14
67
2.12
1.77
1.1
2.0
133.44
137.24
g/l
—
9
46
6
18
3.36
1.75
1.0
1.3
—
—
—
0
0
92
1163
0.75
1.75
1.2
1.3
1.69
1.86
u/ml
0.08
24
325
35
228
1.57
1.69
1.0
1.4
130.85
250.67
miu/ml
1.30
13
122
493
4706
1.33
1.62
4.0
3.9
4.77
4.75
mmol/l
0.11
477
4455
60
799
0.72
1.61
1.2
1.2
39.06
31.33
iu/ml
0.14
14
271
10
45
2.24
1.47
1.1
1.2
—
—
—
0
0
12
59
2.06
1.44
1.1
1.3
—
—
—
0
0
6
22
2.74
1.43
1.2
1.1
104.00
101.16
u/l
—
6
22
6
22
2.74
1.43
1.2
1.1
42.50
22.76
u/l
—
6
22
9
39
2.33
1.43
2.0
1.5
—
—
—
0
0
45
616
0.71
1.43
3.9
2.2
2.40
2.42
mmol/l
0.83
40
547
20
120
1.69
1.36
1.5
2.0
12.58
10.35
mg/l
0.42
20
113
0
37
0.00
1.35
0.0
1.1
—
1.25
—
0
31
495
4755
1.29
1.33
4.1
4.2
2.87
2.87
mmol/l
0.01
480
4479
36
252
1.46
1.30
1.7
2.0
17.19
8.19
ug/l
0.49
30
230
11
201
0.54
1.23
1.5
1.7
—
—
—
0
0
10
187
0.53
1.21
1.8
1.7
—
—
—
0
0
27
181
1.52
1.20
2.9
2.3
130.56
133.12
g/l
0.23
27
176
8
38
2.12
1.19
1.6
1.2
31.27
31.96
nmol/l
—
8
30
199
1772
1.19
1.17
3.4
2.9
—
—
—
0
0
342
3644
0.85
1.14
3.5
3.8
14.60
14.58
pmol/l
0.07
320
3346
17
103
1.67
1.14
1.5
1.4
306.75
332.05
ug/g
—
8
51
160
1401
1.20
1.13
3.7
2.6
28.87
42.36
ng/l
0.70
110
788
7
30
2.35
1.12
1.4
1.6
—
—
—
0
0
121
1033
1.22
1.11
3.3
2.9
1.02
1.02
kg/l
0.19
15
128
116
987
1.22
1.10
3.1
2.2
—
—
—
0
0
8
41
1.96
1.09
1.9
1.5
—
—
—
0
0
8
41
1.96
1.09
1.9
1.5
—
—
—
0
0
15
89
1.70
1.08
1.2
1.2
—
—
—
0
0
62
772
0.78
1.07
1.2
1.2
11.82
10.47
u/ml
0.05
23
322
8
148
0.53
1.05
1.1
1.1
—
—
—
0
0
8
149
0.53
1.05
1.1
1.1
—
—
—
0
0
12
202
0.59
1.03
1.7
1.4
—
—
—
0
0
10
53
1.90
1.02
1.3
1.4
—
—
—
0
0
105
894
1.21
1.00
3.0
2.1
—
—
—
0
0
10
54
1.87
0.97
1.1
1.2
—
—
—
0
0
9
52
1.74
0.92
1.0
1.9
—
—
—
0
0
350
3303
1.15
0.91
4.0
3.6
11.92
9.19
mm/h
2.78
323
3059
5
102
0.49
0.90
1.8
1.2
6.40
8.87
e6/l
—
5
76
5
102
0.49
0.90
2.0
1.3
459.60
1225.54
e6/l
—
5
78
20
288
0.68
0.89
3.8
2.3
123.86
3730.02
u/l
—
7
119
43
337
1.30
0.84
1.5
1.7
—
—
—
0
0
14
89
1.59
0.82
4.4
3.1
18.21
24.87
mg/l
—
8
50
418
4339
0.87
0.80
3.9
4.3
6.49
2.34
mu/l
0.42
397
4036
161
1455
1.15
0.76
2.0
1.7
98.26
97.69
pmol/l
0.06
111
754
88
758
1.19
0.76
1.4
1.6
181481900.35
13473481.50
pmol/l
0.70
81
668
11
67
1.65
0.75
1.1
1.1
—
—
—
0
0
5
24
2.09
0.74
1.4
1.5
—
—
—
0
0
41
326
1.28
0.74
13.0
7.4
0.54
0.87
mmol/l
0.36
35
255
7
38
1.85
0.73
1.6
1.4
—
—
—
0
0
7
39
1.80
0.72
1.6
1.4
—
—
—
0
0
23
168
1.38
0.72
2.2
1.7
—
—
—
0
0
24
320
0.74
0.72
1.3
1.3
—
—
—
0
0
5
27
1.86
0.68
1.4
1.4
5.52
6.32
mmol/l
—
5
27
12
78
1.55
0.66
1.0
1.1
—
—
—
0
0
81
923
0.86
0.62
1.3
1.5
—
—
—
0
0
48
401
1.21
0.59
2.4
2.2
13.53
13.80
nmol/l
0.08
43
373
23
297
0.77
0.58
1.3
1.3
—
53.82
—
0
21
11
161
0.68
0.58
1.5
1.5
—
—
—
0
0
6
36
1.67
0.57
1.0
1.1
—
—
—
0
0
18
135
1.34
0.51
1.2
1.3
—
—
—
0
0
84
939
0.88
0.50
3.4
3.6
23.06
21.54
%
0.38
43
389
26
207
1.27
0.50
1.5
1.4
—
—
—
0
0
26
207
1.27
0.50
1.5
1.4
—
—
—
0
0
26
207
1.27
0.50
1.5
1.4
—
—
—
0
0
26
207
1.27
0.50
1.5
1.4
—
—
—
0
0
6
41
1.47
0.50
1.0
1.2
—
—
—
0
0
12
84
1.44
0.49
1.0
1.0
1.82
2.12
u/ml
—
6
38
110
1206
0.89
0.49
1.5
1.6
—
—
—
0
0
27
217
1.26
0.49
3.8
2.2
66.09
34.27
u/ml
0.26
27
212
5
32
1.57
0.42
2.6
1.7
105.60
105.88
mmol/l
—
5
32
5
32
1.57
0.42
1.6
1.5
—
—
—
0
0
14
183
0.76
0.41
1.6
1.5
—
—
—
0
0
33
278
1.20
0.41
2.4
3.5
4.43
4.63
pmol/l
0.61
28
253
0
17
0.00
0.40
0.0
1.2
—
8.05
—
0
17
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
27
224
1.22
0.39
1.6
1.5
—
—
—
0
0
131
1220
1.10
0.38
3.6
3.1
0.00
0.00
estimate
0.80
38
429
6
44
1.37
0.34
1.5
1.6
—
—
—
0
0
6
87
0.69
0.33
1.2
1.7
—
—
—
0
0
31
358
0.86
0.32
1.0
1.2
207.67
149.72
iu/ml
—
9
142
62
681
0.90
0.31
2.7
2.6
0.76
0.71
ug/l
0.25
47
396
31
269
1.16
0.30
2.8
3.9
122.97
4.98
ug/l
0.48
25
215
18
148
1.22
0.29
1.2
2.3
—
—
—
0
0
8
107
0.74
0.29
1.8
1.2
3.93
3.66
mmol/l
—
8
99
8
62
1.29
0.28
1.0
1.0
1.70
1.40
g/l
—
8
57
26
300
0.86
0.27
1.1
1.1
—
—
—
0
0
22
255
0.86
0.25
1.1
1.6
3.47
3.11
mg/l
0.11
13
185
6
84
0.71
0.24
2.0
4.2
64.00
56.94
%
—
6
84
11
88
1.25
0.22
1.0
1.2
—
—
—
0
0
57
616
0.92
0.22
1.4
1.6
—
—
—
0
0
16
135
1.19
0.21
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
8
101
0.79
0.21
2.3
1.4
2.96
0.37
nmol/l
—
8
84
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
10.85
—
0
13
31
278
1.12
0.20
1.5
1.3
22.89
24.67
iu/l
0.11
23
241
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
6
50
1.20
0.19
7.0
2.9
31.18
80.11
u/ml
—
6
50
17
147
1.16
0.18
1.1
1.6
0.21
0.24
g/l
0.96
17
137
121
1161
1.05
0.18
1.6
1.6
1.38
1.42
mmol/l
0.20
111
991
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
12
101
1.19
0.16
1.8
1.5
—
—
—
0
0
49
461
1.07
0.14
2.5
2.8
7.96
6.07
umol/l
0.32
42
397
21
190
1.11
0.13
20.4
9.2
1.16
1.46
%
0.63
21
190
17
152
1.12
0.12
2.2
2.0
0.66
0.67
%
0.00
17
152
17
153
1.11
0.11
1.1
1.5
1.10
1.19
g/l
1.26
17
143
21
192
1.10
0.11
20.7
9.1
0.62
0.67
%
0.21
21
192
48
505
0.95
0.11
4.5
5.4
—
—
—
0
0
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
8
90
0.89
0.07
1.5
1.2
—
—
—
0
0
39
403
0.97
0.04
1.6
1.5
—
—
—
0
0
67
656
1.02
0.04
3.0
2.9
210.83
610.32
ng/l
0.78
46
427
13
122
1.07
0.02
2.0
1.7
—
—
—
0
0
452
4509
1.01
0.02
5.1
3.8
5.58
5.79
mmol/l
5.00
435
4197
10
93
1.08
0.02
1.0
1.4
—
—
—
0
0
26
266
0.98
0.00
1.3
1.4
—
—
—
0
0
10
104
0.96
0.00
1.0
1.2
0.46
3.53
u/ml
—
5
58
24
245
0.98
0.00
1.9
1.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
50.17
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_DONORS_ORGANS_TISSU – Donors of organs and tissues
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).